NAP

SKU: orb3053924

Description

Davunetide is an eight amino acid peptide (NAPVSIPQ) with potent neuroprotection in vitro and in vivo. Davunetide has been shown to enhance functional daily behaviors in schizophrenia patients and to increase memory scores in patients suffering from amnestic mild cognitive impairment.

Key Properties

• CAS Number: 211439-12-2
• MW: 824.94
• Purity: >98% (HPLC)
• Formula: C₃₆H₆₀N₁₀O₁₂
• Solubility: DMSO : 125 mg/mL (151.53 mM; ultraphonic; ) H2O : 100 mg/mL (121.22 mM; ultraphonic)

Bioactivity

• In Vivo:
  Animal model: Male Sprague-Dawley rats (Induced by an i.p. streptozotocin (STZ) injection). Dosage: 2 μg/kg. Administration: Intranasally beginning on the day following the STZ injection and were given daily, 5 days a week, for 16 weeks. Result: Impaired spatial memory of the diabetic rats was observed in the water maze by attenuated learning curve and worsened performance in the probe memory test. Davunetide treatment significantly improved both measurements.

Storage & Handling

• Storage: Storage temperature: -20°C. Stability: ≥ 2 years
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only